{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-017846","form_type":"8-K","ticker":"AVR","cik":"0002011514","company_name":"Anteris Technologies Global Corp.","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.379272+00:00","generated_at":"2026-05-15T02:24:46.685843+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Anteris terminates v2v development deal, pays $400K break fee","bullets":["Notified v2vmedtech of discontinuation of development contributions after Stage 1 completion.","Break fee of $400,000 payable to v2v; no further contribution obligations.","v2v shareholders may either buy back Anteris' equity at cost or reduce it to capped minority.","Related Development Agreement will terminate upon break fee payment.","Company expects no material adverse effect on consolidated financial position."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-017846","json":"https://secwatch.observer/filing/0001140361-26-017846.json","markdown":"https://secwatch.observer/filing/0001140361-26-017846.md","text":"https://secwatch.observer/filing/0001140361-26-017846.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/0001140361-26-017846-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/ef20071159_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T02:24:46.685843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d101b5cd3a3903344a0b4e1f0d80ad9058e0af7e","claim":"Anteris Technologies Global Corp. terminated Contribution and Stock Purchase Agreement with v2vmedtech, inc. valued at break fee of $400,000 (effective 2026-04-28).","evidence_excerpt":"On April 28 , 2026, Anteris Technologies Global Corp., through its wholly owned subsidiary, Anteris Technologies Corporation (the “Company”), notified v2vmedtech, inc. (“v2v”) of its election to discontinue additional development contributions under the Contribution and Stock Purchase Agreement dated April 18, 2023 (the “Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/0001140361-26-017846-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001213900-26-054200","ticker":"SERV","company_name":"Serve Robotics Inc. /DE/","filed_at":"2026-05-11T23:59:59+00:00","headline":"Serve Robotics ends $150M ATM sales agreement, reports pro forma Q1 net loss of $51M from Diligent acquisition","event_type":"other_material","sec_items":["1.02","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: material_agreement","same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-054200","json":"https://secwatch.observer/filing/0001213900-26-054200.json","markdown":"https://secwatch.observer/filing/0001213900-26-054200.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832483/000121390026054200/0001213900-26-054200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832483/000121390026054200/ea028960901-8k_serve.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 28 , 2026, Anteris Technologies Global Corp., through its wholly owned subsidiary, Anteris Technologies Corporation (the “Company”), notified v2vmedtech, inc. (“v2v”) of its election to discontinue additional development contributions under the Contribution and Stock Purchase Agreement dated April 18, 2023 (the “Agreement”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/0001140361-26-017846-index.htm","comparable_excerpt":"On May 7, 2026, Serve Robotics Inc. (the “Company”) and each of Cantor Fitzgerald & Co., Wedbush Securities Inc., Northland Securities, Inc., Ladenburg Thalmann & Co. Inc. and Seaport Global Securities LLC (collectively, the “Agents”) agreed to terminate the Controlled Equity Offering SM Agreement, dated as of March 6, 2025 (the “Prior Sales Agreement”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1832483/000121390026054200/0001213900-26-054200-index.htm"}},{"accession":"0001140361-26-019761","ticker":"BBIO","company_name":"BridgeBio Pharma, Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"BridgeBio Pharma establishes $500M at-the-market equity offering program","event_type":"other_material","sec_items":["1.01","1.02","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: material_agreement","same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-019761","json":"https://secwatch.observer/filing/0001140361-26-019761.json","markdown":"https://secwatch.observer/filing/0001140361-26-019761.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1743881/000114036126019761/0001140361-26-019761-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1743881/000114036126019761/ny20072667x2_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 28 , 2026, Anteris Technologies Global Corp., through its wholly owned subsidiary, Anteris Technologies Corporation (the “Company”), notified v2vmedtech, inc. (“v2v”) of its election to discontinue additional development contributions under the Contribution and Stock Purchase Agreement dated April 18, 2023 (the “Agreement”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/0001140361-26-017846-index.htm","comparable_excerpt":"On May 7, 2026, in connection with entering into the Agreement, the Company agreed with Goldman Sachs and Leerink Partners (formerly known as SVB Securities LLC), to terminate that certain Equity Distribution Agreement, dated May 4, 2023, by and among the Company, Goldman Sachs and Leerink Partners, effective as of May 7, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1743881/000114036126019761/0001140361-26-019761-index.htm"}},{"accession":"0001740797-26-000011","ticker":"AVAI","company_name":"AVAI BIO, INC.","filed_at":"2026-05-08T23:59:59+00:00","headline":"AVAI Bio and Ainnova Tech mutually terminate JV agreement as of May 7, 2026","event_type":"other_material","sec_items":["1.02","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: material_agreement","same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001740797-26-000011","json":"https://secwatch.observer/filing/0001740797-26-000011.json","markdown":"https://secwatch.observer/filing/0001740797-26-000011.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1740797/000174079726000011/0001740797-26-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1740797/000174079726000011/avai_8kmay82026.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 28 , 2026, Anteris Technologies Global Corp., through its wholly owned subsidiary, Anteris Technologies Corporation (the “Company”), notified v2vmedtech, inc. (“v2v”) of its election to discontinue additional development contributions under the Contribution and Stock Purchase Agreement dated April 18, 2023 (the “Agreement”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/0001140361-26-017846-index.htm","comparable_excerpt":"On May 7, 2026, Avai Bio, Inc., formerly known as Avant Technologies Inc. (the “Company” or “AVAI”), and Ainnova Tech Inc. (“Ainnova” or “AINN”) entered into a Mutual Termination Agreement (the “Termination Agreement”) to terminate, by mutual consent, the Joint Venture and License Agreement dated November 8, 2024 (effective as of November 11, 2024) (the “License Agreement”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1740797/000174079726000011/0001740797-26-000011-index.htm"}},{"accession":"0001829126-26-004794","ticker":"QETA","company_name":"Quetta Acquisition Corp","filed_at":"2026-05-08T23:59:59+00:00","headline":"Quetta Acquisition cancels $1.04M in promissory notes with KM Quad","event_type":"other_material","sec_items":["1.02","8.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-004794","json":"https://secwatch.observer/filing/0001829126-26-004794.json","markdown":"https://secwatch.observer/filing/0001829126-26-004794.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1978528/000182912626004794/0001829126-26-004794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1978528/000182912626004794/quettaacq_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 28 , 2026, Anteris Technologies Global Corp., through its wholly owned subsidiary, Anteris Technologies Corporation (the “Company”), notified v2vmedtech, inc. (“v2v”) of its election to discontinue additional development contributions under the Contribution and Stock Purchase Agreement dated April 18, 2023 (the “Agreement”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/0001140361-26-017846-index.htm","comparable_excerpt":"On April 30, 2026, Quetta Acquisition Corporation (the “Company”) entered into that certain Release and Discharge of Promissory Notes (the “Release”) with KM Quad, a Cayman Islands exempted company (“KM Quad”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1978528/000182912626004794/0001829126-26-004794-index.htm"}},{"accession":"0001408534-26-000035","ticker":"FGBI","company_name":"First Guaranty Bancshares, Inc.","filed_at":"2026-05-05T23:59:59+00:00","headline":"First Guaranty Bank buys back three properties from related party for $14.77M, terminates leases","event_type":"other_material","sec_items":["1.02"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: material_agreement","same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001408534-26-000035","json":"https://secwatch.observer/filing/0001408534-26-000035.json","markdown":"https://secwatch.observer/filing/0001408534-26-000035.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1408534/000140853426000035/0001408534-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1408534/000140853426000035/fgbi-20260429.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 28 , 2026, Anteris Technologies Global Corp., through its wholly owned subsidiary, Anteris Technologies Corporation (the “Company”), notified v2vmedtech, inc. (“v2v”) of its election to discontinue additional development contributions under the Contribution and Stock Purchase Agreement dated April 18, 2023 (the “Agreement”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/0001140361-26-017846-index.htm","comparable_excerpt":"In connection with the purchase of the Properties by the Bank, the Bank and FGB Partners terminated the Lease Agreements.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1408534/000140853426000035/0001408534-26-000035-index.htm"}},{"accession":"0000927089-26-000084","ticker":"USCB","company_name":"USCB FINANCIAL HOLDINGS, INC.","filed_at":"2026-05-01T23:59:59+00:00","headline":"USCB terminates Side Letter Agreement with Patriot Financial Partners; Patriot's rep resigned from board","event_type":"other_material","sec_items":["1.02","1.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: material_agreement","same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000927089-26-000084","json":"https://secwatch.observer/filing/0000927089-26-000084.json","markdown":"https://secwatch.observer/filing/0000927089-26-000084.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1901637/000092708926000084/0000927089-26-000084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1901637/000092708926000084/uscbf20260427_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 28 , 2026, Anteris Technologies Global Corp., through its wholly owned subsidiary, Anteris Technologies Corporation (the “Company”), notified v2vmedtech, inc. (“v2v”) of its election to discontinue additional development contributions under the Contribution and Stock Purchase Agreement dated April 18, 2023 (the “Agreement”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/0001140361-26-017846-index.htm","comparable_excerpt":"On April 29, 2026, USCB Financial Holdings, Inc. (the Company”) and its wholly owned subsidiary, U.S. Century Bank (the “Bank” and collectively with the Company, the “USCB Parties”)) entered into a Mutual Termination Agreement with Patriot Financial Partners II, L.P. (“Patriot Financial”) and Patriot Financial Partners Parallel II, L.P. (\"Patriot Financial Parallel” and together with Patriot Financial, “Patriot”), to terminate the rights and obligations of the Patriot and the USCB parties set forth in the Side Letter Agreement dated December 30, 2021 (the “Side Letter Agreement”) entered into by and among the Company, the Bank, Patriot and Priam Capital Fund II, LP (“Priam”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1901637/000092708926000084/0000927089-26-000084-index.htm"}},{"accession":"0001193125-26-197481","ticker":"STRT","company_name":"STRATTEC SECURITY CORP","filed_at":"2026-04-30T23:59:59+00:00","headline":"Strattec's JV replacement credit agreement releases company from guaranty obligations","event_type":"other_material","sec_items":["1.02"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: material_agreement","same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-197481","json":"https://secwatch.observer/filing/0001193125-26-197481.json","markdown":"https://secwatch.observer/filing/0001193125-26-197481.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/933034/000119312526197481/0001193125-26-197481-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933034/000119312526197481/strt-20260430.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 28 , 2026, Anteris Technologies Global Corp., through its wholly owned subsidiary, Anteris Technologies Corporation (the “Company”), notified v2vmedtech, inc. (“v2v”) of its election to discontinue additional development contributions under the Contribution and Stock Purchase Agreement dated April 18, 2023 (the “Agreement”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/0001140361-26-017846-index.htm","comparable_excerpt":"Effective as of April 30, 2026, ADAC-STRATTEC, LLC (“ADAC-STRATTEC”), a majority owned joint venture subsidiary of Strattec Security Corporation (the “Company”), entered into an Amended and Restated Credit Agreement with BMO Bank N.A. (the “New JV Credit Agreement”) that replaced ADAC-STRATTEC’s existing credit agreement, dated June 28, 2012, with BMO Bank N.A.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/933034/000119312526197481/0001193125-26-197481-index.htm"}},{"accession":"0001653909-26-000006","ticker":"BIRD","company_name":"Allbirds, Inc.","filed_at":"2026-04-29T23:59:59+00:00","headline":"Allbirds enters new ATM equity distribution agreement; terminates prior TD facility","event_type":"other_material","sec_items":["1.01","1.02","9.01"],"materiality_score":0.45,"calibrated_materiality_score":0.45,"match_reasons":["same fact type: material_agreement","same SEC item: 1.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001653909-26-000006","json":"https://secwatch.observer/filing/0001653909-26-000006.json","markdown":"https://secwatch.observer/filing/0001653909-26-000006.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653909/000165390926000006/0001653909-26-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653909/000165390926000006/bird-20260427.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 28 , 2026, Anteris Technologies Global Corp., through its wholly owned subsidiary, Anteris Technologies Corporation (the “Company”), notified v2vmedtech, inc. (“v2v”) of its election to discontinue additional development contributions under the Contribution and Stock Purchase Agreement dated April 18, 2023 (the “Agreement”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/0001140361-26-017846-index.htm","comparable_excerpt":"On April 28, 2026, the Company entered into a Class A Common Stock Sales Agreement (the “ Sales Agreement ”) with Chardan Capital Markets LLC (“ Chardan ”), to sell shares of its Class A Common Stock (the “ ATM Shares ”), from time to time, through an “at the market offering” program","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1653909/000165390926000006/0001653909-26-000006-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}